Pharmacokinetics: Pediatrics

Slides:



Advertisements
Similar presentations
DISPOSITION OF DRUGS The disposition of chemicals entering the body (from C.D. Klaassen, Casarett and Doull’s Toxicology, 5th ed., New York: McGraw-Hill,
Advertisements

SEMINAR ON ALTERED KINETICS IN PEDIATRICS
CHAPTER 3 Life Span Considerations
6/10/20151Prof. Mazen Qato. Objectives At the end of this sessions students should be able to: 1. List and discuss common routes of drug administration.
Factors Affecting Distribution and Metabolism. Chemical Factors Lipophilicity Structure Ionization Chirality.
Pharmacokinetics of Drug Absorption
Asmah Nasser, M.D. Pharmacokinetics.
Pharmacokinetics Chapter 4.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 10 Drug Therapy in Pediatric Patients.
Pharmacokinetics: Bioavailability Asmah Nasser, M.D.
Objectives Describe the main physiological changes that occur with aging Identify factors affecting absorption and distribution with the geriatric client.
Pharmacology Department
Lecture 2.  Clearance Ability to eliminate the drug  Volume of distribution (Vd) The measure of the apparent space in the body available to contain.
RATIONAL DRUG THERAPY DR.SELVAN. INTRODUCTION Choosing a safe and effective treatment regimen for pediatric patients can be challenging. Multiple patient.
Bioavailability Dr Mohammad Issa.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
PHARMACOKINETICS Part 3.
Special Populations: Pediatrics Arthur G. Roberts.
CLINICAL PHARMACY AGE FACTORS: FEATURES OF THE RATIONAL USE OF MEDICINES.
Factoid: Is there a difference in blood flow (Q) between an athlete and non- athlete? Blood flow increases during exercise. At rest, blood flow is similar.
CHAPTER 7 ABSORPTION KINETICS.
TDM Therapeutic Drug Monitoring
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 3 Life Span Considerations.
Introduction to Pharmacology and Pharmacokinetics Pharmacology Bill Diehl-Jones RN, PhD Faculty of Nursing and Department of Zoology.
Copyright ©2008 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Focus on Pharmacology, First Edition By Jahangir Moini.
Pharmacokinetics 2 General Pharmacology M212
Foundation Knowledge and Skills
Pharmacokinetics: Digoxin Allie Punke
METABOLISME DEPARTMENT OF PHARMACOLOGY AND THERAPEUTIC UNIVERSITAS SUMATERA UTARA dr. Yunita Sari Pane.
Effect of Renal Disease on Pharmacokinetics
Allie punke Pharmacokinetics tutoring Fall 2016
Basic Principles: PK By: Alaina Darby.
Pediatric Considerations
Drug therapy in pediatric
Pediatric Pharmacotherapy Clinical Pearls
Kinetics Tutoring Allie Punke.
Excretion of drugs.
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacology I BMS 242 Lecture II (Continued)
Life Span Consideration
CHAPTER 7 ABSORPTION KINETICS.
Allie punke Pharmacokinetics tutoring Fall 2016
By: Dr. Roshini Murugupillai
Drug Metabolism Drugs are most often eliminated by biotransformation and/or excretion into the urine or bile. The process of metabolism transforms lipophilic.
Pharmacokinetics.
Anticonvulsants: Valproic acid
Pharmacokinetics: Pediatrics
Pharmaceutics 2.
Pharmacology I BMS 242 Lecture II (Continued)
Drug Therapy in Pediatric Patients
Pharmacokinetics: Theophylline
Factors affecting Drug Activity
Pharmcokinetics Allie punke.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Pharmcokinetics Allie punke.
Pharmacokinetics: Metabolism of Drugs
Pharmacokinetics and Factors of Individual Variation
Pharmacokinetics: Drug Absorption
Drug Therapy for Pediatric Clients
Selected Bioavailability and Pharmacokinetic Calculations
Biopharmaceutics 4th year
Clinical Pharmacokinetics
Pharmacokinetics: Drug Absorption
Biopharmaceutics and pharmacokinetic by: Anjam Hama A. M. Sc
Clinical Pharmacokinetics
BIOAVAILABILITY.
Pharmacokinetics/Pharmacodynamics
Therapeutic Drug Monitoring
Medication Administration for Pediatrics
Drug Therapy in Pediatric Patients
Presentation transcript:

Pharmacokinetics: Pediatrics Allie Punke (apunke@uthsc.edu)

The Basics—True or False Pediatric patients generally require higher doses of lipophilic drugs (like diazepam) due to increased fat content at birth The Schwartz equation can be used to estimate creatinine clearance, but caution should be used for interpreting the results within the first week of life Cystic fibrosis patients typically require lower doses of aminoglycosides due to production of thick mucus making it more difficult to eliminate the medication Hydroxylation is the most developed phase I reaction in pediatric patients. False True False (hydrolysis is)

Absorption Pediatrics

Absorption An acid labile drug such as ampicillin is ordered for a neonate. How do you expect the dosing to differ for a neonate versus an adult? A. An adult will likely require a higher dose due to mature elimination pathways. B. An infant will likely require a higher dose because the drug will not be absorbed as well. C. An adult will likely require a lower dose because of the lower total body water content in adults. D. An infant will likely require a lower dose because the drug will exhibit a higher bioavailability.

Absorption How should phenobarbital, a weak acid, be adjusted for pediatric patients? A. Dosing should be increased because it is not absorbed as well in pediatric patients B. Dosing should be decreased because of increased bioavailability C. Dosing should be increased because pediatric patients are eliminating it much faster D. Dosing should be decreased because pediatric patients are not able to eliminate it as fast

Absorption The pH is more (acidic or alkaline) at birth? Patients who are fed Q4 hours each should be expected to have (constant production of acid or a peak in acid production when fed)? Pediatric patients reach adult gastric output of acid around what age? The ________, the ___________ the gastric emptying time. A. Younger, shorter B. Older, longer C. Younger, longer

Absorption Patients fed with formula are expected to experience (shorter or longer) gastric emptying times than human milk fed patients. Because most drugs are absorbed in the _______, pediatric patients most likely should not be given _________. A. stomach, immediate release B. small intestine, enteric coated C. stomach, sustained release D. colon, immediate release Longer gain weight faster

Absorption What are issues to consider when giving medications by these routes: Topically IM Rectal Intraosseous

Distribution Pediatrics

Distribution Pediatric patients typically require: A. Smaller doses of hydrophilic drugs such as aminoglycosides B. Smaller doses lipophilic drugs such as aminoglycosides C. Larger doses of hydrophilic drugs such as diazepam D. Larger doses of hydrophilic drugs such as aminoglycosides D

Distribution What are some examples of medications that should be used with caution due to displacement of endogenous protein bound substrates (like bilirubin)? IV lipids, Phenobarbarital, salicylates, sulfonamides, phenytoin, propranolol, lidocaine, PCN, nafcillin, chloramphenicol

Metabolism Pediatrics

Metabolism Which drug is least likely to be affected in a neonate? A. A drug undergoing hydroxylation B. A drug undergoing glucuronidation C. A drug undergoing oxidation D. A drug undergoing hydrolysis D (Hydrolysis=most developed). Sulfation is also most developed phase II reaction

Metabolism Drugs may undergo different metabolic pathways in pediatric patients due to immaturity of some pathways How is acetaminophen metabolized in a neonate? How is theophylline’s metabolism different in a neonate?

Elimination Pediatrics

Elimination When should the Schwartz equation not be used in pediatric patients? Calculate Creatinine clearance for a full term infant who is 24 weeks old. Length=60cm, SCr=0.3

Summary Pediatric patients have increased total body water and decreased total body fat. Recognize how this can affect drug dosing (i.e. higher doses for water soluble drugs) Recognize the different routes of administration available and which may or may not be the best If given the metabolic pathway of a medication, be able to determine if it will likely be affected Know the Schwartz equation and be able to calculate a CrCl for pediatric patients

Questions? Good luck on your exam!